NCCN / Oncology Clinical Protocols
Hyper-CVAD (Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, Dexamethasone alternating with High-Dose Methotrexate and Cytarabine)
Pharmaceutical companies and oncology drug manufacturers.
Hyper-CVAD (Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, Dexamethasone alternating with High-Dose Methotrexate and Cytarabine)
BEP (Bleomycin, Etoposide, Cisplatin (Platinol))
FOLFIRI-CETUXIMAB (Leucovorin, 5-Fluorouracil, Irinotecan, Cetuximab)
Gleevec (imatinib mesylate)
Alkeran for Injection (Melphalan Hydrochloride)
Alimta (Pemetrexed Disodium)
Alemtuzumab (Alemtuzumab)
Alectinib (Alectinib)
Afatinib Dimaleate (Afatinib Dimaleate)
Alecensa (Alectinib)
Aldesleukin (Aldesleukin)
Aldara (Imiquimod)